Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by retiredcopon Dec 27, 2019 12:08pm
108 Views
Post# 30494125

RE:RE:Directors review

RE:RE:Directors reviewtopbroker... i have a mug at home that says I am the best grandpa in the world... that makes me feel that I am the best but any other grandpa will say he is the best . so its really just a impression we have of our greatness that we express to others 

I just wanted to comment on one of your evaluations of a director... I also thought  Johannes Roth was not doing anything .. but as I dug deeper and interacted with different investors I suddenly realized that he was actually promoting the company behind the scenes in ways that most of us could not. You may have seen that he is a long time director of a company called Powerplug that trades on NASD. Back in 2016 we had a big new york investor with the initials MB that accumulated over 14M shares of Promis. MB is also a heavy investor in Powerplug and has a direct link to JR. MB brought along alot of US investors who still own a high percentage of PMN stocks. So maybe to much haste on your part only looking at what is available on the internet. Last question... have you contacted any one in the company... at least Ray Blanco made personal visits with the company before he made his recommendations and he  accumulated alot of PMN stocks. 

If you have not conatcted any of the directors or sceintists ... then you really have no idea what is happening behind the scenes... reach out  to them... but not till after Jan 4 .. every one other the PR lady are off line...    

   
 
Bullboard Posts